Getinge Group Interim report January

Reporting period January – March

  ·
Order intake increased by 20.3% to SEK 7,192 M (5,977), and grew organically by
2.2%

  ·
Net sales rose by 19.2% to SEK 6,712 M (5,632), and grew organically by 1.4%

  ·
Profit before tax increased to SEK 146 M (-452)

  ·
Net profit increased to SEK 107 M (-330)

  ·
Earnings per share amounted to SEK 0.38 (-1.39)

  ·
EBITA before restructuring costs increased by 7.0% to SEK 717 M (670)

  ·
Operating cash flow increased by 49.3% to SEK 654 M (438)

  ·
Agreement concerning Consent Decree with US FDA

Getinge Group Interim report January – March 2015

Attachments